Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta

By Pieternella S in 't Anker, S. Scherjon, C. Kleijburg-van der Keur, G. D. de Groot-Swings, F. Claas, W. Fibbe, H. Kanhai. Stem Cells, 2004

1,223 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. (2007, background): “www.aacrjournals.org 9147 Cancer Res 2007; 67: ( 19 ).”
Mesenchymal stromal cells: new directions. (2012, background): “…MSC populations can be obtained readily from adipose tissue (Zuk et al., 2002) and also from a variety of tissues including placenta (In ’t Anker et al., 2004), skin (Shih et al., 2005), umbilical cord blood (Erices et al., 2000), umbilical cord perivascular cells (Sarugaser et al.,…”
Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. (2008, background): “Multipotent mesenchymal stromal cells (MSC) are obtained from a variety of adult and fetal tissues, including cord blood [4], dental pulp [5], adipose tissue [6], skin [7], muscle [8], liver [9], synovium [10], pancreas [11], lung [12], amniotic fluid [13], placenta [14], peripheral blood [15], and ”